Evidence map›Paper›PMID 28806762›Full record

ArticlePLoS genetics2017

A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease.

Altea Rocchi, Soh Yamamoto, Tabitha Ting, Yuying Fan, Katherine Sadleir, Yigang Wang, Weiran Zhang, Sui Huang, Beth Levine, Robert Vassar and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 2 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Autophagy activation by the Becn1Brain, behavior, and immunity · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Altea RocchiDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Soh YamamotoDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Tabitha TingCenter for Autophagy Research, Department of Internal Medicine, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.ORCID http://orcid.org/0000-0001-5206-9243
Yuying FanDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Katherine SadleirDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Yigang WangDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Weiran ZhangDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Sui HuangDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Beth LevineCenter for Autophagy Research, Department of Internal Medicine, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.ORCID http://orcid.org/0000-0002-1460-1638
Robert VassarDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Congcong HeDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.ORCID http://orcid.org/0000-0001-5563-9096
Northwestern University · USHoward Hughes Medical Institute · US

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROGALSKI, EMILY J · 1996 to 2020
$28.9M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
BACE1 as a Therapeutic Target for Alzheimer's DiseaseR01AG022560 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 2003 to 2017
$4.6M
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's DiseaseR01AG030142 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 2007 to 2019
$3.1M
Beclin 1-Bcl-2 Interactions: Effects on AutophagyR01CA109618 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LEVINE, BETH C · 2004 to 2014
$3.1M
The Structure and Function of Perinucleolar CompartmentR01GM078555 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HUANG, SUI · 2007 to 2015
$2.6M
NCI NIH HHS R01 CA109618NIAID NIH HHS T32 AI007163NIAID NIH HHS U19 AI109725NIA NIH HHS P30 AG013854NIA NIH HHS R01 AG022560NIA NIH HHS R01 AG030142NIGMS NIH HHS R01 GM078555
6 · The paper itself

Abstract

Impairment of the autophagy pathway has been observed during the pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder characterized by abnormal deposition of extracellular and intracellular amyloid β (Aβ) peptides. Yet the role of autophagy in Aβ production and AD progression is complex. To study whether increased basal autophagy plays a beneficial role in Aβ clearance and cognitive improvement, we developed a novel genetic model to hyperactivate autophagy in vivo. We found that knock-in of a point mutation F121A in the essential autophagy gene Beclin 1/Becn1 in mice significantly reduces the interaction of BECN1 with its inhibitor BCL2, and thus leads to constitutively active autophagy even under non-autophagy-inducing conditions in multiple tissues, including brain. Becn1F121A-mediated autophagy hyperactivation significantly decreases amyloid accumulation, prevents cognitive decline, and restores survival in AD mouse models. Using an immunoisolation method, we found biochemically that Aβ oligomers are autophagic substrates and sequestered inside autophagosomes in the brain of autophagy-hyperactive AD mice. In addition to genetic activation of autophagy by Becn1 gain-of-function, we also found that ML246, a small-molecule autophagy inducer, as well as voluntary exercise, a physiological autophagy inducer, exert similar Becn1-dependent protective effects on Aβ removal and memory in AD mice. Taken together, these results demonstrate that genetically disrupting BECN1-BCL2 binding hyperactivates autophagy in vivo, which sequestrates amyloid oligomers and prevents AD progression. The study establishes new approaches to activate autophagy in the brain, and reveals the important function of Becn1-mediated autophagy hyperactivation in the prevention of AD.

Indexed as

CognitionAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAutophagyBeclin-1Disease Models, AnimalGene Knock-In TechniquesHEK293 CellsHeLa CellsHumansIn Situ Nick-End LabelingMaleMemoryMiceMice, Inbred C57BLAmyloid beta-PeptidesBcl2 protein, mouseBeclin-1Becn1 protein, mouseProto-Oncogene Proteins c-bcl-2

Identifiers

PMID28806762
PMCPMC5570506
OpenAlexW2749882665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.